+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pioglitazone"

Insulin Drugs Global Market Report 2024 - Product Thumbnail Image

Insulin Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Global Anti-diabetic Drugs Market - Product Thumbnail Image

Global Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 500 Pages
  • United States
From
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Pioglitazone is a drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as thiazolidinediones, which work by increasing the body's sensitivity to insulin. Pioglitazone is used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes. It can also be used to reduce the risk of cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Pioglitazone is a widely used drug in the endocrine and metabolic disorders drug market. It is used to treat type 2 diabetes, a condition that affects millions of people worldwide. Pioglitazone is generally well tolerated and has been shown to improve glycemic control and reduce the risk of cardiovascular events in adults with type 2 diabetes. Some companies in the pioglitazone market include Takeda Pharmaceuticals, Merck & Co., Sanofi, and Eli Lilly. Show Less Read more